Kali-Extracts Announces Developing Cannabis Pain Management

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
52
Kali-Extracts Announces Developing Cannabis Pain Management Treatment For $83 Billion Market Specifically Targeting Cancer

DALLAS, April 04, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Kali-Extracts, Inc. (Kali, Inc. dba/Kali-Extracts, Inc.) (USOTC: KALY) (“KALY”) today announced its ongoing research and development of a cannabis pain management treatment derived from the company’s patented cannabis extraction process.  While cannabis for pain management treatment from cancer is not new, KALY is developing a proprietary extract that improves upon the cannabis treatments currently approved by the FDA.  The FDA approved a marijuana treatment for aiding in the management of cancer symptoms and the side effects of other cancer treatments in 1985. That drug, marinol, is a synthetic form of the marijuana cannabinoid THC and is used to treat both chemotherapy-induced nausea and HIV-related weight loss.  The market for generic marinol is approximately $300 million per year.  KALY’s cannabis extract is not a synthetic.  The overall pain management treatment market is anticipated to reach $83 billion by 2024 .

Earlier this week, KALY announced its ongoing research and development of a cannabis treatment for Type 2 Diabetes.  Kali-Extracts, through its patented cannabis extraction process, is developing a variety of treatments for various health issues.  KALY recently published a research report on its pilot cannabis treatment for Chronic Obstructive Pulmonary Disease (COPD).  KALY is currently in the progress of beginning to disclose its additional research and development of cannabis extracts for additional health issues.  The company currently has ongoing cannabis extract research and development targeting four specific health issues, COPD, Type 2 Diabetes, Cancer Pain Management and one additional health issue KALY plans to announce next week leading up to an online presentation with more detail on each of the treatment developments later this month.  The market for Type 2 Diabetes is expected to be a $64 billion market by 2026 .  The market for COPD treatment is anticipated to reach $14 billion by 2025 . Beyond the four specific cannabis therapies currently in various stages of research and development, KALY has a number of additional target therapies in its research pipeline.

In addition to its pharmaceutical developments, KALY is generating revenue from is patented cannabis extraction process delivering proprietary extracts for infusion into non-pharmaceutical commercial products.  KALY announced last week finalizing it’s all new 25 mg CBD Extract formulation for beverage infusion.  KALY’s patented extraction process already produces a 10 mg CBD formulation for Puration, Inc.’s (USOTC: PURA) (“PURA”) leading EVERx CBD Sports Water.  KALY has also recently announced plans to provide commercial extraction for Nouveau, Inc. (USOTC: NOUV) (“NOUV”) in conjunction with NOUV’s recently announced 100-acre hemp farm.

KALY is a health and wellness company set to generate revenue from its patented cannabis extraction technology through overlapping go-to-market strategies.  In addition to developing pharmaceutical products internally and through partnerships, KALY is utilizing its patented cannabis extraction process to develop numerous wellness products both internally and through partnerships. The first revenue generating contracts signed in December of 2018 will be reflected in the company’s upcoming annual report.

To learn more about the company visit https://www.kali-extracts.com/

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. These forward looking statements relate to, amongst other things, current expectation of the business environment in which the company operates, potential future performance, projections of future performance and the perceived opportunities in the market. The company's actual performance, results and achievements may differ materially from the expressed or implied in such forward-looking statements as a result of a wide range of factors.

CONTACT: Frederick Ferri ir@kali-extracts.com (214) 210-0459

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hemlo Mining's Q3 2026: Steady Gold Amid Challenges

Updated Category News Views 110

Gold Output Amid Operational Hiccups The old saying that rough seas make tough sailors could've been penned for Hemlo Mining during its third quarter this year. They clocked in a notable 25,652 ounces of gold. The revenue charted at $135.5 million, a bit of a slide down the pole if you're comparing to the second quarter, thanks to a dip in gold prices. But let’s weigh...

Continue Reading
PMET Exec Shakeup as Shaakichiuwaanaan Nears Development

Updated Category News Views 18

Turning Wheels at PMET: Leadership Shuffle in Motion There's a changing of the guard over at PMET Resources as they brace for the next big steps with their Shaakichiuwaanaan Project. Ken Brinsden, their long-time President and CEO, has decided it's time to pass the baton down the line, transitioning to Executive Chair next year. This move is all about keeping a steady...

Continue Reading
Supermetrics Debuts AI Campaign Manager for Marketers

Updated Category News Views 88

These days, digital marketing feels like trying to build a puzzle in a sandstorm. You've got all these pieces flying around, valuable insights buried somewhere in the mix, and you can't just toss 'em together however you like. Supermetrics steps into this whirlwind with their new tool, Campaign Manager, promising marketers a direct line from insight to action. Finally, a...

Continue Reading
Lauri Thompson Joins UWSN Board: A New Era Begins

Updated Category News Views 108

Fresh Faces and New Perspectives In a move that merges legal acumen with community heart, Lauri S. Thompson of Greenberg Traurig has stepped up as a board member for the United Way of Southern Nevada (UWSN). Now, why should we care about this? Because when someone with Thompson's clout and eight-arm octopus of involvement links up with a nonprofit, things get interesting....

Continue Reading
Michelle T. Boone's Impactful Tenure at Poetry Foundation

Updated Category News Views 6

When Michelle T. Boone took the helm of the Poetry Foundation back in May 2021, the nonprofit world, much like the rest of us, was living through unprecedented times. Even then, Boone wasn't one to shy away from a challenge. Spotting opportunities when others see chaos is a talent most seasoned leaders possess, and Boone demonstrated just that by nudging the Foundation...

Continue Reading
High Stakes at Bragg Companies' Crane Auction

Updated Category News Views 19

Cranes, Cash, and Competition: Auction Insights Never thought a bunch of cranes and trucks could have me so interested, but here we are staring down one of the big ones this December. Bragg Companies plans to lift the lid on its fleet with an absolute auction conducted by none other than Jeff Martin Auctioneers. If you aren't in the loop, 'absolute' means no min bid,...

Continue Reading
Lazard's October 2026 AUM: Navigating Market Swings

Updated Category News Views 49

October AUM: Ups and Downs for Lazard God, if there's one constant in the world of investment, it's that nothing stays the same—and Lazard's latest asset under management (AUM) report proves it. Released with all the flair of a late-night diner special, the report shows Lazard's AUM came in at $282.4 billion as of October 31, 2026. Not earth-shattering at first glance,...

Continue Reading
Bybit Enhances Copy Trading with Fine-Tuned Filters

Updated Category News Views 54

Fine-tuning in the Wild West of Copy Trading Pull up a chair, because this is one for the books. Bybit, that sprawling new financial playground trusted by 80 million folks around the globe, just laid another stone on the path to trading enlightenment with their Copy Trading Classic. They’ve cranked up the ability to sift through Master Traders like a prospector panning...

Continue Reading
MIT Study: Reinforced Masonry Slashes Hurricane Damage

Updated Category News Views 87

Building Smarter: Concrete vs. The Storm Hurricanes are nature’s wrecking balls, and if there’s one thing the latest MIT study tosses on the table, it’s that reinforced concrete masonry isn't just holding its ground—it's changing the game. You see, when Hurricane Irma swung through Florida, it left a clear message written in the rubble: smarter building means...

Continue Reading
Ellsworths Unveil 'jetty' Brand Aiming to Shake Up Hydration

Updated Category News Views 26

Diving Headfirst into the Hydration Trenches It seems Stephen and Allison Ellsworth can't sit still for long. They've come out swinging yet again, this time unveiling their new hydration brand, 'jetty', poised to stir up the $13 billion electrolyte drink industry. These folks aren’t just dipping their toes in either—they're plunging right in with a product line...

Continue Reading

Top 5 Most Recently Viewed Articles

Impact of Tariffs on Federal Reserve's Monetary Policy Decisions

Updated Category News Views 325

Understanding the Influence of Tariffs on Monetary Policy Jerome Powell, the Chair of the Federal Reserve, expressed that the central bank's approach to monetary policy has been significantly influenced by tariff strategies initiated by former President Donald Trump. During a recent panel discussion, he revealed insights about how these tariffs affected the central bank's...

Continue Reading
Navigating the Evolving Cystinosis Treatment Landscape

Updated Category News Views 149

Understanding the Cystinosis Treatment Landscape The cystinosis treatment landscape is experiencing significant transformation, predominantly driven by established cysteamine-based therapies. Despite the current options, there is a notable scarcity of next-generation treatments that offer curative or disease-modifying effects. Fortunately, emerging therapies are evolving...

Continue Reading
Understanding Quiet Cracking: A New Look at Employee Burnout

Updated Category News Views 185

Understanding the Phenomenon of Quiet Cracking in the Workplace Recent findings shed light on a significant issue facing employees today called "quiet cracking." This term refers to a troubling situation wherein workers meet their job responsibilities while battling burnout, emotional fatigue, and disengagement from their work. The latest survey indicates that nearly six...

Continue Reading
Tevogen Bio's Clinical Trial Shows Hope for Long COVID Treatments

Updated Category News Views 80

Tevogen Bio's Groundbreaking Clinical Trial Results Tevogen Bio has made headlines with its impressive clinical trial data regarding its innovative treatment, TVGN 489. This trial is particularly vital as it targets individuals affected by Long COVID, a condition that continues to challenge healthcare systems worldwide. The company is committed to addressing this pressing...

Continue Reading
MetaVia Initiates Fat Loss Study with DA-1726: Phase 1 Results

Updated Category News Views 163

MetaVia Launches Phase 1 Trial for Obesity Treatment MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company, has made significant strides in its journey toward transforming the approach to cardiometabolic diseases. Recently, the company announced that it has successfully dosed its first patient in a Phase 1 clinical trial dedicated to evaluating DA-1726, a...

Continue Reading